Alexander Fleming

Alexander Fleming
Official photographer · Public domain · source
Name	Alexander Fleming
Birth date	6 August 1881
Birth place	Lochfield, Darvel, Ayrshire
Death date	11 March 1955
Death place	London
Nationality	United Kingdom
Fields	Bacteriology, Pharmacology
Alma mater	St Mary's Hospital Medical School, University of London
Known for	Discovery of penicillin
Awards	Nobel Prize (1945), Order of Merit

Alexander Fleming (6 August 1881 – 11 March 1955) was a Scottish physician, bacteriology researcher and pharmacology scientist best known for the discovery of penicillin and its antibacterial properties. His work at St Mary's Hospital Medical School and later at the Sir William Dunn School of Pathology contributed to transformative changes in medical practice, surgery, and the treatment of infectious diseases, leading to global public health impacts and recognition including the Nobel Prize in Physiology or Medicine.

Early life and education

Born in Lochfield, Darvel in Ayrshire, he was the third of four children of a family with Scottish Presbyterian roots. After early schooling in Darvel and in London when the family moved, he trained at St Mary's Hospital Medical School, affiliated with the University of London, where he qualified as a physician and later undertook postgraduate work in London hospitals. His formative influences included mentors and contemporaries at St Mary's Hospital Medical School and scientific figures active in Edwardian-era British medical research.

Medical and research career

Following qualification, he served as a physician and surgeon at St Mary's Hospital and joined the First World War medical effort as part of the Royal Army Medical Corps, treating wounded soldiers suffering from infected wounds and gas exposure. Back in peacetime London, he held posts in clinical bacteriology and pathology at the St Mary's Hospital Medical School and at the Sir William Dunn School of Pathology in Oxford, collaborating with technicians, clinicians and researchers from institutions such as the Ministry of Health and various university departments. His laboratory work focused on bacteriology of wound infections, antisepsis, and the interaction between microbes and host tissues, bringing him into professional contact with contemporaries and organizations in British and international medical research networks.

Discovery of penicillin

In 1928, while working at the St Mary's Hospital Medical School laboratory, he observed that a mould contaminant on a bacterial culture plate inhibited growth of Staphylococcus aureus. The contaminant was identified as a species of the genus Penicillium, and he characterized the substance released by the mould—naming it "penicillin"—and published his observations in scientific journals. His initial reports described the antibacterial activity in vitro and in vivo against common pathogenic bacteria responsible for wound infections and sepsis, and proposed potential therapeutic applications. Despite the promise, his early attempts at purification and clinical application were limited by chemical instability and production difficulties, and wider development required later partnership with researchers and institutions in Oxford and in industrial laboratories.

Later research and honours

During the late 1930s and through World War II, further development and mass production of penicillin involved scientists and organizations including researchers at the University of Oxford's Sir William Dunn School of Pathology, industrial partners, and government programs aimed at scaling up fermentation and purification. For his role in the discovery and early characterization of penicillin, he shared the Nobel Prize in Physiology or Medicine in 1945 with Howard Florey and Ernst Boris Chain. He received numerous other honours such as appointment to the Order of Merit and election to learned societies. Beyond penicillin, his laboratory investigations addressed topics in bacteriology including antibacterial enzymes, antiseptics, and immune responses, and he continued to publish and lecture internationally, influencing research agendas at institutions across Europe and North America.

Impact, legacy, and controversies

The introduction and mass production of penicillin precipitated a revolution in clinical medicine, reducing mortality from infected wounds, pneumonia, and post-surgical sepsis, and shaping the rise of modern antibiotic therapy. The discovery stimulated pharmaceutical innovation, industrial fermentation efforts, and public health strategies in institutions like national health services and military medicine. Over ensuing decades, the widespread use of penicillin and subsequent antibiotics led to the emergence of antibiotic resistance, prompting scientific, clinical and policy debates involving researchers, hospitals and regulatory bodies. Historians and scientists have discussed attribution and the collaborative nature of penicillin's development, noting contributions from laboratory staff, clinical trial teams, industrial chemists, and government programs; these discussions involve figures and organizations such as Howard Florey, Ernst Boris Chain, Norman Heatley, and various university and corporate laboratories. Fleming's name endures in medical education, commemorative institutions, museums and awards, and in the eponymous prizes and lectures established by universities and scientific societies.

Category:Scottish scientists Category:1881 births Category:1955 deaths